1 Schroeder SA, Warner KE. Don’t Forget Tobacco. N Engl J Med 2010;363:201–4.
2 American Cancer Society. The Tobacco Atlas. Drope J, Schluger NW, editors. Sixth Edition. 2018. Atlanta, Georgia 30303 USA, American Cancer Society.
3 Navas-Acien A. Global Tobacco Use: Old and New Products. Ann Am Thorac Soc 2018;15(Supplement 2):69–75.
4 Knishkowy B, Amitai Y. Water-pipe (narghile) smoking: an emerging health risk behavior. Pediatrics 2005;116(1):e113–e119.
5 Maziak W, Taleb ZB, Bahelah R, Islam F, Jaber R, Auf R et al. The global epidemiology of waterpipe smoking. Tob Control 2018;Suppl 1:i3–i12.
6 Barry RA, Hiilamo H, Glantz SA. Waiting for the opportune moment: The tobacco industry and marijuana legalization. Milbank Q 2014;92(2):207–42.
7 Haffajee RL, MacCoun RJ, Mello MM. Behind Schedule – Reconciling Federal and State Marijuana Policy. N Engl J Med 2018;379(6):501–4.
8 Richter KP, Levy S. Big marijuana – lessons from big tobacco. N Engl J Med 2014;371(5):399–401.
9 Barben J. Cannabis-Legalisierung – wer profitiert davon? Schweizerische Ärztezeitung 2018;99(48):1710–2.
10 Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B et al. Smoking prevalence and cigarette consumption in 187 countries,1980–2012. JAMA 2014;311(2):183–92.
11 Gmel G, Kuendig H, Notari L, Gmel C. Sucht Schweiz – Bundesamt Für Gesundheiswesen. Suchtmonitoring Schweiz – Konsum von Alkohol, Tabak und illegalen Drogen in der Schweiz im Jahr 2016. Lausanne, Schweiz 2017
12 Jakob J, Cornuz J, Diethelm P. Prevalence of tobacco smoking in Switzerland: do reported numbers underestimate reality? Swiss Med Wkly 2017;May 11(147):w14437.
13 Marmet S, Archimi A, Windlin B, Delgrande Jordan M. Substanzkonsum bei Schülerinnen und Schülern in der Schweiz im Jahr 2014 und Trend seit 1986 – Resultate der Studie «Health Behaviour in School–aged Children» (HBSC). Forschungsbericht Nr. 75. 2015. Lausanne Schweiz, Sucht Schweiz.
14 National Cancer Institute and Centers for DiseaseControl and Prevention. Smokeless tobacco and public health: A global perspective. Publication No. 14-7983. 2014. Bethesda, MD: U.S, Department of Health and Human Services, Centers for Disease Control and Prevention and National Institutes of Health, National Cancer Institute. NIH.
15 Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncol 2008;9:667–75.
16 Critchley JA, Unal B. Health effects associated with smokeless tobacco: A systematic review. Thorax 2003;58:435–443.
17 Rostron BL, Chang JT, Anic GM, anwar M, hang CM, orey CG. Smokeless tobacco use and circulatory disease risk: a systematic review and meta-analysis. Open Heart 2018;5(2):e000846.
18 Vidyasagaran AL, Siddiqi K, Kanaan M. Use of smokeless tobacco and risk of cardiovascular disease: A systematic review and meta-analysis. Eur J Prev Cardiol 2016;23(18):1970–1981.
19 Frey A. Snus-Tabak boomt in der Schweiz. NZZ am Sonntag 2018 Jun 3;S. 57.
20 Luo J, Ye W, Zendehdel K, Adami J, Adami HO, Boffetta P et al. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2018;369(9578):2015–2020.
21 Gartner CE, Hall WD, Vos T, Bertram MY, Wallace AL, Lim SS. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet 2018;369(9578):2010–2014.
22 World Health Organization. Tobacco: deadly in any form or disguise. 2006.
23 Boyle P, Yasantha Ariyaratne MA, Barrington R, Bartelink H, Bartsch G, Berns A et al. Tobacco: deadly in any form or disguise. Lancet 2006;367(9524):1710–12.
24 Wang TW, Gentzke A, Sharapova S, Cullen KA, Ambrose BK, Jamal A. Tobacco Product Use Among Middle and High School Students – United States,2011–2017. MMWR Morb Mortal Wkly Rep 2018;67(22):629–33.
25 Schuurmans MM, Barben J. Factsheet 3: Wasserpfeife/Shisha. Primary and Hospital Care – Allgemeine Innere Medizin 2018;18(2):31–5.
27 von Rappard J, Schönenberger M, Bärlocher L. Carbon monoxide poisoning following use of a water pipe/hookah. Dtsch Arztebl Int 2014; 111(40):674–9.
28 El-Zaatari ZM, Chami HA, Zaatari GS. Health effects associated with waterpipe smoking. Tob Control 2015; 24:i31–i43.
29 Montazeri Z, Nyiraneza C, El-Katerji H, Little J. Waterpipe smoking and cancer: systematic review and meta-analysis. Tob Control 2017; 26(1):92–7.
30 Shihadeh A, Schubert J, Klaiany J, El Sabban M, Luch A, Saliba NA. Toxicant content, physical properties and biological activity of waterpipe tobacco smoke and its tobacco-free alternatives. Tob Control 2015;(Suppl 1):i22–i30.
31 Kaelin R, Barben J, Schuurmans MM. Elektronische Zigaretten, E-Shishas und «heat, but not burn devices». Schweiz Med Forum 2017; 17(5):113–9.
32 McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev 2014; 12:CD010216.
33 Halpern SD, Harhay MO, Saulsgiver K, Brophy C, Troxel AB, Volpp KG. A Pragmatic Trial of E-Cigarettes, Incentives, and Drugs for Smoking Cessation. N Engl J Med 2018; 378(24):2302–10.
34 Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med 2016; 4(2):116–28.
35 Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. N Engl J Med 2019; 380(7):629–37.
36 ERS Tobacco Control Committee. ERS Position Paper on Tobacco Harm Reduction. 2019, May 29.
https://www ersnet org/advocacy/eu-affairs/ers-position-paper-on-tobacco-harm-reduction-2019.
37 Barben J, Runge C. E-Zigaretten und E-Shishas – eine neue Gefahr für unsere Kinder. Pädiatrische Praxis 2016; 85(4):525–34.
38 Miech R, Johnston L, O’Malley PM, Bachman JG, Patrick ME. Adolescent vaping and Nicotin Use in 2017–2018 – U.S. National Estimates. N Engl J Med 2018; 380(2):192–3.
39 Zhu SH, Sun JY, Bonnevie E, Cummins SE, Gamst A, Yin L et al. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control 2014; 23(Suppl3):iii3–iii9.
40 Soneji S, Sargent J, Tanski S. Multiple tobacco product use among US adolescents and young adults. Tob Control 2016; 25(2):174–80.
41 Adams AJ, Banister SD, Irizarry L, Trecki J, Schwartz M, Gerona R. «Zombie» Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York. N Engl J Med 2017; 376(3):235–42.
42 Pourchez J, Forest V. E-cigarettes: from nicotine to cannabinoids,the French situation. Lancet Respir Med 2018; 6(5):e16-
doi: 10.1016/S2213–2600(18)30069–9.
43 Barrington–Trimis JL, Leventhal AM. Adolescents’ Use of «Pod Mod» E-Cigarettes – Urgent Concerns. N Engl J Med 2018;379 (12):1099–102.
44 Schröder T. E-Zigarette Juul will Europa erobern. NZZ am Sonntag 2018 Jul 8;S. 27.
45 Duffy EK, Jenssen BP. Electronic cigarettes: the new face of nicotine. Pediatrics 2014; 134(1):1–3.
46 Soneji S, Barrington–Trimis JL, Wills TA, Leventhal AM, Unger JB, Gibson LA et al. Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults: A Systematic Review and Meta-analysis. JAMA Pediatr 2017; 171(8):788–97.
47 Scheven F. Die E-Zigarette liegt bei Jugendlichem im Trend. Neue Zürcher Zeitung 2018 Jun 15;S. 24.
48 Barben J, Hammer J. Internationale Lungenfachgesellschaften warnen vor E-Zigaretten. Schweizerische Ärztezeitung 2018; 99(37):1235–7.
49 Dinakar C, O’Connor GT. The Health Effects of Electronic Cigarettes. N Engl J Med 2016; 375(14):1372–81.
50 ERS Tobacco Control Committee. ERS position paper on heated tobacco products.
https://www ersnet org/the-society/news/ers-position-paper-on-heated-tobacco-products [ 2018
51 Gornall J. Public Health England’s troubled trail. BMJ 2015; 351:h5826.
52 McKee M, Capewell S. Evidence about electronic cigarettes: a foundation built on rock or sand? BMJ 2015;(351):h4863.
53 Auer R, Concha-Lozano N, Jacot-Sadowski I, Cornuz J, Berthet A. Heat-Not-Burn Tobacco Cigarettes: Smoke by Any Other Name. JAMA Intern Med 2018; 177(7):1050–2.
54 Jensen RP, Luo W, Pankow JF, Strongin RM, Peyton DH. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med 2015; 372(4):392–4.
55 Stephens WE. Comparing the cancer potencies of emissions from vapourised nicotine products including e-cigarettes with those of tobacco smoke. Tob Control 2018; 27:10–17.
56 Chun LF, Moazed F, Calfee CS, Matthay MA, Gotts JE. Pulmonary toxicity of e-cigarettes. Am J Physiol Lung Cell Mol Physiol 2017; 313(2):L193–L206.
57 Ferkol TW, Farber HJ, La Grutta S, Leone FT, Marshall HM, Neptune E et al. Electronic cigarette use in youths: a position statement of the Forum of International Respiratory Societies. Eur Respir J 2018; 51(5):Epup ahead-
doi: 10.1183/13993003.00278–2018.
58 Suris JC, Michaud PA, Viner R. The adolescent with a chronic condition. Part I: developmental issues. Arch Dis Child 2018; 89(10):938–42.
59 Tercyak KP, Tyc VL. Opportunities and challenges in the prevention and control of cancer and other chronic diseases: children’s diet and nutrition and weight and physical activity. J Pediatr Psychol 2006; 31(8):750–63.
60 Benowitz NL. Nicotine Addiction. N Engl J Med 2010; 362:2295–303.
61 Deutsches Krebsforschungszentrum. Schutz der Familie vor Tabakrauch. Rote Reihe Tabakprävention und Tabakkontrolle[Band 14], 1–90. 2010. Heidelberg.
62 Leonardi-Bee J, Jere ML, Britton J. Exposure to parental and sibling smoking and the risk of smoking uptake in childhood and adolescence: a systematic review and meta-analysis. Thorax 2011; 66(10):847–55.
63 Barben J. Tabaklobby und Kinderfänger – wie cool ist rauchen wirklich. Teil 1: Tabakepidemie, Werbung und Manipulation. Schweiz Med Forum 2011; 11:370–5.
64 Barben J. Tabaklobby und Kinderfänger – wie cool ist rauchen wirklich. Teil 2: Passivrauchen und Strategien der Tabakindustrie. Schweiz Med Forum 2011; 11:389–93.
65 Warner KE. Tobacco control policies and their impacts. Past, present, and future. Ann Am Thorac Soc 2014; 11(2):227–30.
66 Diethelm PA, McKee M. Lifting the smokescreen – Tobacco industry strategy to defeat smoke free policies and legislation. European Respiratory Society, Institut National du Cancer (INCa F, editors. 1–28. 2006.
67 Daube M, Moodie R, McKee M. Towards a smoke-free world? Philip Morris International’s new Foundation is not credible. Lancet 2018; 390(10140):1722–4.
68 Goldberg DS, Lederer DJ, MacKenzie EJ, Moss M, Samet JM, Schumacker PT et al. The Phillip Morris Foundation for a Smoke-Free World. A Cause for Concern. Ann Am Thorac Soc 2018; 15(11):1269–72.
69 Angeli T, Hostettler O. Rauchen: Neue Tricks – alte Lügen. Beobachter 2018 Mar 16;
https://www.beobachter.ch/wirtschaft/rauchen-neue-tricks-alte-lugen.
71 Fischer B. Für BAT-Schweiz-Chefin ist Rauchen keine Frage der Moral. Handelszeitung 2016 Sep 22.
72 Henkel CH. Altria greift für Juul tief in die Tasche. Neue Zürcher Zeitung 2018 Dec 21;S.30.
73 Cami J, Farré M. Drug addiction. N Engl J Med 2003; 349:975–86.
74 Burki TK. Big tobacco turns its attention to Africa. Lancet Respir Med 2018; 6(5):329.